None listed
Conditions
Interventions
Intervention1: Eltior Skin-Reset Cleanser: Marketed By: Relaner Ventures Pvt. Ltd.
Route of Application: Topical
Mode of Usage: Participants will be instructed to wet the face with water and dispens
Sponsors
Relaner Ventures Pvt. Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1) Ages 18-55 years both inclusive. 2) Males and non-pregnant/non-lactating females 3) Females with self-reported negative pregnancy test 4) Having general good health and has both eyes. 5) Understand the test procedures and agree to adhere to study requirements, instructions and procedures. 6) Pass an eye sting evaluation using isotonic saline. 7) Willing to refrain from using any eye drops on the day of the study. 8) In general, good health as determined by the Investigator on the basis of medical history. 9) Willig and able to follow the study protocol to participate in the study. 10) Able to understand and provide written Participant s information sheet to participate in the study. 11) Willing not to use any other marketed product on application site during the study period.
Exclusion criteria
Exclusion criteria: 1) Having any known allergy to test product ingredient. 2) Presence of any chronic disease or illness in the past three months or any clinically significant on-going chronic medical illness e.g. Congestive cardiac failure, Hepatitis, Hypotensive episodes, etc. 3) Participation in any similar consumer study within the past 90 days. 4) Currently using any topical medications. 5) Any exceptions to the inclusion/exclusion criteria will be considered on a case-by case basis and will be documented in the case report form. 6) Currently or within the last 2 weeks using eye drops (such as saline solutions, Netra-Prabha, Drasty, etc.). 7) Have participated in a study with the eyes as the target area within 6 weeks of the start of the study. 8) Be involved in any aspect of study administration, i.e., evaluating applying products, etc. 9) Have a history of sensitivity and/or adverse reactions to preparations intended for the eyes. 10) Currently having any eye infections or irritation. 11) The participant is having any sensitivity to eye make-up. 12) Currently have any eye infections or irritation including blepharitis, general lid inflammation, conjunctivitis, or an eye discharge within two weeks of the study. 13) Currently using any topical medications on the face or any medications intended for the eyes. 14) Have taken antihistamines (including those in cold tablets, OTC allergy medications, decongestants and inhalants) on the days of the study. 15) Have any other condition or factor that the Investigator or Ophthalmologist believes may affect the stinging or tearing response or the interpretation of the results. 16) Currently taking any prescription pain medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To assess the effect of the test product for change in: 1. Skin Hydration 2. Skin overall dryness 3. Consumer Perception Questionnaire 4. Ocular irritation 5.degree of inflammation of bulbar conjunctiva, palpebral conjunctiva, and lacrimationTimepoint: From the baseline before test product usage on Day 01 and after test product usage at T0 (+20) mins on Day 01. | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: NA | — |
Countries
India
Contacts
Public ContactMaheshvari Patel
NovoBliss Research Pvt. Ltd.
Outcome results
None listed